483 Sun Pharmaceutical Industries Apr 2017

483 Sun Pharmaceutical Industries Apr 2017

Sony Mathews FDA, Daniel Roberts FDA$119.00 - Available Now

FDA investigators audited the Sun Pharmaceutical Industries - Dadra, India facility and issued inspectional observations (via FDA 483) on 13 Apr 2017.

Add To Cart

Product details

  • Category: Human Drugs
  • Inspection end: 13 Apr 2017
  • Location: Dadra, India